Free Trial

Editas Medicine (EDIT) SEC Filings & 10K Form

Editas Medicine logo
$3.17 -0.11 (-3.35%)
(As of 04:27 PM ET)

Recent Editas Medicine SEC Filings

DateFilerForm TypeView
11/04/2024
10:57 AM
Editas Medicine (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
6:36 AM
Editas Medicine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
6:33 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
6:04 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
12:10 PM
Editas Medicine (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
09/06/2024
3:18 PM
Editas Medicine (Issuer)
O'Neill Gilmore Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
3:20 PM
Editas Medicine (Issuer)
Mei Baisong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
6:06 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
4:02 PM
Burkly Linda (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
4:01 PM
Editas Medicine (Issuer)
Mei Baisong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
6:23 PM
Editas Medicine (Subject)
Mei Baisong (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/18/2024
3:17 PM
Burkly Linda (Reporting)
Editas Medicine (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2024
5:28 AM
Editas Medicine (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
06/27/2024
4:02 PM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
5:04 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
4:11 PM
Editas Medicine (Issuer)
Hirsch Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
4:13 PM
Chatterjee Meeta (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
4:14 PM
Editas Medicine (Issuer)
Hopfield Jessica (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
4:15 PM
Editas Medicine (Issuer)
Scadden David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:30 PM
Editas Medicine (Issuer)
Reeve Emma (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
3:30 PM
Editas Medicine (Issuer)
Lucera Erick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
3:32 PM
Editas Medicine (Subject)
Lucera Erick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2024
3:17 PM
Editas Medicine (Issuer)
Hopfield Jessica (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
3:21 PM
Editas Medicine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
6:08 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
3:30 PM
Editas Medicine (Filer)
Form DEFA14A
04/16/2024
3:25 PM
Editas Medicine (Filer)
Form DEF 14A
04/10/2024
8:37 AM
Editas Medicine (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
03/05/2024
6:54 PM
Editas Medicine (Issuer)
Mei Baisong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM
Editas Medicine (Issuer)
O'Neill Gilmore Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:03 PM
Burkly Linda (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:06 PM
Editas Medicine (Issuer)
Lucera Erick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
4:13 PM
Editas Medicine (Filer)
Form S-3ASR
02/28/2024
3:39 PM
Editas Medicine (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2024
6:06 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
7:40 AM
Deep Track Capital, LP (Filed by)
Editas Medicine (Subject)
Form SC 13G/A
01/24/2024
1:27 PM
BlackRock Inc. (Filed by)
Editas Medicine (Subject)
Form SC 13G/A
01/10/2024
8:09 AM
Editas Medicine (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
12/13/2023
8:02 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2023
3:23 PM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2023
3:30 PM
Eaton Bruce (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

Register For The Webinar To Discover
11/22/2023
3:10 PM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2023
3:30 PM
Eaton Bruce (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:EDIT) was last updated on 11/7/2024 by MarketBeat.com Staff
From Our Partners